Synthesis, characterization and antimicrobial activity of novel Schiff base tethered boronate esters of 1,2-O-isopropylidene-α-d-xylofuranose.
暂无分享,去创建一个
R. Prakasham | Rajiv Trivedi | B. Sridhar | E. R. Reddy | A. V. Sarma | B. Sudheer Kumar | K. Sirisha | A. Sarma
[1] B. Sumerlin,et al. Synthesis and Applications of Boronic Acid-Containing Polymers: From Materials to Medicine. , 2016, Chemical reviews.
[2] E. Aubert,et al. Synthesis, characterization, crystal structure and DFT study of two new polymorphs of a Schiff base (E)-2-((2,6-dichlorobenzylidene)amino)benzonitrile , 2016 .
[3] Shujun Li,et al. Synthesis, antimicrobial activity of Schiff base compounds of cinnamaldehyde and amino acids. , 2016, Bioorganic & medicinal chemistry letters.
[4] F. Şahin,et al. The synthesis of boronic-imine structured compounds and identification of their anticancer, antimicrobial and antioxidant activities☆ , 2015, Journal of pharmaceutical analysis.
[5] P. Yogeeswari,et al. Sugar-boronate ester scaffold tethered pyridyl-imine palladium(II) complexes: synthesis and their in vitro anticancer evaluation. , 2015, Dalton transactions.
[6] B. Elewski,et al. Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies. , 2015, Journal of the American Academy of Dermatology.
[7] Kelly A McCarthy,et al. Targeting Bacteria via Iminoboronate Chemistry of Amine-Presenting Lipids , 2015, Nature Communications.
[8] D. Gowda,et al. Schiff's bases of quinazolinone derivatives: Synthesis and SAR studies of a novel series of potential anti-inflammatory and antioxidants. , 2015, Bioorganic & Medicinal Chemistry Letters.
[9] C. Ganesh Kumar,et al. Synthesis, antimicrobial and anti-biofilm activities of novel Schiff base analogues derived from methyl-12-aminooctadec-9-enoate. , 2014, Bioorganic & medicinal chemistry letters.
[10] Chaoliang He,et al. Boronic acid shell-crosslinked dextran-b-PLA micelles for acid-responsive drug delivery. , 2014, Macromolecular bioscience.
[11] Changsheng Shi,et al. Fabrication of boronic acid-functionalized nanoparticles via boronic acid–diol complexation for drug delivery , 2014 .
[12] Y. Miyahara,et al. New directions in the design of phenylboronate-functionalized polymers for diagnostic and therapeutic applications , 2014 .
[13] He-Fang Wang,et al. Aminophenylboronic-acid-conjugated polyacrylic acid-Mn-doped ZnS quantum dot for highly sensitive discrimination of glycoproteins. , 2014, Analytical chemistry.
[14] J. Trujillo-Ferrara,et al. Boron-containing compounds: chemico-biological properties and expanding medicinal potential in prevention, diagnosis and therapy , 2014, Expert opinion on therapeutic patents.
[15] V. Barba,et al. Boron Macrocycles Based on Multicomponent Assemblies using (3-Aminophenyl)boronic Acid and Pentaerythritol as Common Reagents; Molecular Receptors toward Lewis Bases , 2014 .
[16] C. A. Gray,et al. Heterocyclic Aminoboron Compounds as Antituberculosis Agents , 2014 .
[17] Chi Wu,et al. One stone kills three birds: novel boron-containing vesicles for potential BNCT, controlled drug release, and diagnostic imaging. , 2014, Molecular pharmaceutics.
[18] Rajiv Trivedi,et al. Carbohydrate‐Based Ferrocenyl Boronate Esters: Synthesis, Characterization, Crystal Structures, and Antibacterial Activity , 2013 .
[19] Y. Miyahara,et al. Phenylboronic acid-installed polymeric micelles for targeting sialylated epitopes in solid tumors. , 2013, Journal of the American Chemical Society.
[20] Sha Long,et al. Schiff Bases: A Short Survey on an Evergreen Chemistry Tool , 2013, Molecules.
[21] R. Popa,et al. Sugar-borate esters--potential chemical agents in prostate cancer chemoprevention. , 2013, Anti-cancer agents in medicinal chemistry.
[22] K. Sztanke,et al. An insight into synthetic Schiff bases revealing antiproliferative activities in vitro. , 2013, Bioorganic & medicinal chemistry.
[23] M. Smietana,et al. Boron and nucleic acid chemistries: merging the best of both worlds. , 2013, Chemical Society reviews.
[24] G. Kabalka,et al. Boronated carbohydrate derivatives as potential boron neutron capture therapy reagents. , 2013, Future medicinal chemistry.
[25] P. Ramachandran. Focusing on boron in medicinal chemistry. , 2013, Future medicinal chemistry.
[26] A. Verma,et al. Boron chemicals in diagnosis and therapeutics. , 2013, Future medicinal chemistry.
[27] P. de Souza,et al. Folate conjugation to polymeric micelles via boronic acid ester to deliver platinum drugs to ovarian cancer cell lines. , 2013, Biomacromolecules.
[28] L. Ciani,et al. Boron as a platform for new drug design , 2012, Expert opinion on drug discovery.
[29] V. Dembitsky,et al. Boron containing compounds as protease inhibitors. , 2012, Chemical reviews.
[30] Zhen Liu,et al. Restricted access boronate affinity porous monolith as a protein A mimetic for the specific capture of immunoglobulin G , 2012 .
[31] R. Raines,et al. Boronate-Mediated Biologic Delivery , 2012, Journal of the American Chemical Society.
[32] F. Gamo,et al. Benzoxaborole antimalarial agents. Part 2: Discovery of fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles. , 2012, Bioorganic & medicinal chemistry letters.
[33] B. Sumerlin,et al. Biomedical applications of boronic acid polymers , 2011 .
[34] J. Balzarini,et al. Activity and safety of synthetic lectins based on benzoboroxole-functionalized polymers for inhibition of HIV entry. , 2011, Molecular pharmaceutics.
[35] S. Benkovic,et al. Boron-containing inhibitors of synthetases. , 2011, Chemical Society reviews.
[36] P. Messersmith,et al. Catechol Polymers for pH-Responsive, Targeted Drug Delivery to Cancer Cells , 2011, Journal of the American Chemical Society.
[37] Rajiv Trivedi,et al. Efficient synthesis, structural characterization and anti-microbial activity of chiral aryl boronate esters of 1,2-O-isopropylidene-α-D-xylofuranose. , 2011, Bioorganic & medicinal chemistry letters.
[38] J. Boucher,et al. Aminoboronic acids and esters: from synthetic challenges to the discovery of unique classes of enzyme inhibitors. , 2011, Chemical Society reviews.
[39] David Benito-Alifonso,et al. Carbohydrate chemistry in drug discovery. , 2011, Organic & biomolecular chemistry.
[40] S. Westcott,et al. Arylspiroboronate esters: from lithium batteries to wood preservatives to catalysis. , 2011, Chemical Society reviews.
[41] V. Dembitsky,et al. Natural and synthetic small boron-containing molecules as potential inhibitors of bacterial and fungal quorum sensing. , 2011, Chemical reviews.
[42] L. Modolo,et al. Schiff bases: A short review of their antimicrobial activities , 2011 .
[43] C. Mcguigan,et al. Boronic acids in medicinal chemistry: anticancer, antibacterial and antiviral applications , 2010 .
[44] R. Popa,et al. Boron-containing compounds as preventive and chemotherapeutic agents for cancer. , 2010, Anti-cancer agents in medicinal chemistry.
[45] D. Hall,et al. Multistep phase-switch synthesis by using liquid-liquid partitioning of boronic acids: productive tags with an expanded repertoire of compatible reactions. , 2010, Angewandte Chemie.
[46] Jing‐Juan Xu,et al. A Reusable Interface Constructed by 3‐Aminophenylboronic Acid‐Functionalized Multiwalled Carbon Nanotubes for Cell Capture, Release, and Cytosensing , 2010 .
[47] Moritz M. Reichvilser,et al. Boronic acid mono- and diesters of the aldopentoses. , 2010, Carbohydrate research.
[48] Hamed I. Ali,et al. Synthesis, antitumor activity and molecular docking study of novel sulfonamide-Schiff's bases, thiazolidinones, benzothiazinones and their C-nucleoside derivatives. , 2010, European journal of medicinal chemistry.
[49] Jin Chen,et al. Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors. , 2009, Bioorganic & medicinal chemistry letters.
[50] Yi Xia,et al. Therapeutic potential of boron-containing compounds. , 2009, Future medicinal chemistry.
[51] M. Lourenço,et al. Synthesis and antitubercular activity of novel Schiff bases derived from d-mannitol. , 2009, Carbohydrate research.
[52] Beat Ernst,et al. From carbohydrate leads to glycomimetic drugs , 2009, Nature Reviews Drug Discovery.
[53] R. Santillán,et al. 3-Aminophenylboronic acid as building block for the construction of calix- and cage-shaped boron complexes , 2009 .
[54] J. Berenson. Hematology: Bortezomib in newly diagnosed multiple myeloma , 2009, Nature Reviews Clinical Oncology.
[55] Stephan M Levonis,et al. Boronolectin with divergent fluorescent response specific for free sialic acid. , 2009, Chemical communications.
[56] Zareen Akhter,et al. N-(3-Nitrobenzylidene)aniline , 2008, Acta crystallographica. Section E, Structure reports online.
[57] D. Matteson. α‐Amido boronic acids: A synthetic challenge and their properties as serine protease inhibitors , 2008 .
[58] N. Petasis. Expanding Roles for Organoboron Compounds – Versatile and Valuable Molecules for Synthetic, Biological and Medicinal Chemistry , 2007 .
[59] Andrea F Armstrong,et al. The bioinorganic and medicinal chemistry of carboranes: from new drug discovery to molecular imaging and therapy. , 2007, Dalton Transactions.
[60] H. Ge,et al. Synthesis and antimicrobial activities of Schiff bases derived from 5-chloro-salicylaldehyde. , 2007, European journal of medicinal chemistry.
[61] P. Yogeeswari,et al. Abacavir prodrugs: microwave-assisted synthesis and their evaluation of anti-HIV activities. , 2006, Bioorganic & medicinal chemistry letters.
[62] C. Ratledge,et al. Schiff base conjugates of p-aminosalicylic acid as antimycobacterial agents. , 2006, Bioorganic & medicinal chemistry letters.
[63] S. Westcott,et al. Palladium salicylaldimine complexes containing boronate esters , 2005 .
[64] D. Steinberg,et al. Synthesis and evaluation of oxazaborolidines for antibacterial activity against Streptococcus mutans. , 2004, Journal of medicinal chemistry.
[65] F. Seela,et al. With Boronic Acids , 2004 .
[66] S. Westcott,et al. Synthesis and antifungal and antibacterial bioactivity of cyclic diamines containing boronate esters , 2003 .
[67] B. Wang,et al. Boronic acid compounds as potential pharmaceutical agents , 2003, Medicinal research reviews.
[68] C. Decicco,et al. P1 Phenethyl peptide boronic acid inhibitors of HCV NS3 protease. , 2002, Bioorganic & medicinal chemistry letters.
[69] T. James,et al. Saccharide-accelerated hydrolysis of boronic acid imines , 2002 .
[70] B. Bassler,et al. Structural identification of a bacterial quorum-sensing signal containing boron , 2002, Nature.
[71] S. Westcott,et al. Synthesis and reactivity of novel Schiff bases containing boronate esters , 2002 .
[72] Chi‐Huey Wong,et al. Carbohydrate-Based Antibiotics: A New Approach to Tackling the Problem of Resistance. , 2001, Angewandte Chemie.
[73] S. Westcott,et al. ChemInform Abstract: Synthesis and Antifungal Properties of Benzylamines Containing Boronate Esters. , 2001 .
[74] Cosima Stubenrauch,et al. Sugar surfactants — aggregation, interfacial, and adsorption phenomena , 2001 .
[75] T. Kawahata,et al. Boromycin, an anti-HIV antibiotic. , 1996, Bioscience, biotechnology, and biochemistry.
[76] Bradley D. Smith,et al. Modification of a Boronic Acid Cleft Produces a Sodium-Saccharide Cotransporter , 1995 .
[77] S. Shinkai,et al. Electrochemical detection of saccharides by the redox cycle of a chiral ferrocenylboronic acid derivative: a novel method for sugar sensing , 1995 .
[78] B. Das,et al. A concise and general entry into (R)-4-hydroxy-2-substituted cyclopent-2-enones from D-glucose: chiral intermediates for the synthesis of PGE2, (–)-pentenomycin I, and allethrin , 1990 .
[79] D. Cremer,et al. General definition of ring puckering coordinates , 1975 .
[80] E. M. Linday. PRACTICAL INTRODUCTION TO MICROBIOLOGY , 1962, The Ulster Medical Journal.
[81] C. Bowman,et al. Cyclic Benzeneboronate Esters , 1958 .
[82] H. Kuivila,et al. ARENEBORONATES FROM DIOLS AND POLYOLS1 , 1954 .